drugset / Trial / NCT02349477

Gabapentin for Alcohol Relapse Prevention

NCT02349477

Phase 2 Completed 96 enrolled Medical University of South Carolina
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This treatment study is a 16-weeks outpatient clinical trial where subjects with alcohol dependence will get medication, which might help them to reduce or stop their drinking, or a placebo ( placebo is a capsule that looks the same as the investigational drug, but has no real medication. It is a "sugar pill").

Timeline

Start
2014-11
Primary completion
2018-08-27
Completion
2018-08-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1200 mg Oral